(Q35873532)

10 August 2017

1 reference

title

Economics of unfractionated heparin: beyond acquisition cost (English)

1 reference

10 August 2017

1 reference

Paul P Dobesh

1

1 reference

10 August 2017

Heparin Consensus Group

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

24

1 reference

10 August 2017

issue

8 Pt 2

1 reference

10 August 2017

page(s)

161S-164S

1 reference

Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

Medical economics and the assessment of value in cardiovascular medicine: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Even

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

Direct Medical Cost of Managing Deep Vein Thrombosis According to the Occurrence of Complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.12.161S.36108

10.1592/PHCO.24.12.161S.36108

21 January 2018

Identifiers

DOI

1 reference

release_2hmmx57b7nh6djwskvx6okjflq

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2hmmx57b7nh6djwskvx6okjflq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference